APA (7th ed.) Citation

van Ommen-Nijhof, A., Jacobse, J. N., Steggink, L. C., Lefrandt, J. D., Gietema, J. A., van Leeuwen, F. E., . . . Sonke, G. S. (2022). Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors. Breast Cancer Research and Treatment, 196(3), 591-602. https://doi.org/10.1007/s10549-022-06714-0

Chicago Style (17th ed.) Citation

van Ommen-Nijhof, Annemiek, Judy N. Jacobse, Lars C. Steggink, Joop D. Lefrandt, Jourik A. Gietema, Flora E. van Leeuwen, Michael Schaapveld, and Gabe S. Sonke. "Adjuvant Aromatase Inhibitor Therapy and Early Markers for Cardiovascular Disease in Breast Cancer Survivors." Breast Cancer Research and Treatment 196, no. 3 (2022): 591-602. https://doi.org/10.1007/s10549-022-06714-0.

MLA (9th ed.) Citation

van Ommen-Nijhof, Annemiek, et al. "Adjuvant Aromatase Inhibitor Therapy and Early Markers for Cardiovascular Disease in Breast Cancer Survivors." Breast Cancer Research and Treatment, vol. 196, no. 3, 2022, pp. 591-602, https://doi.org/10.1007/s10549-022-06714-0.